Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2020

MissionIRNewsBreaks – Knightscope Inc.’s Innovative Technology Featured in Exclusive Broadcast

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), today announced the availability of a broadcast titled, “Technology Answers Call for Greater Public Safety, Crime Prevention.” The broadcast details Knightscope’s technology, designed to augment and … Continue reading

Posted in Knightscope, Inc., MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Net Element Inc. (NASDAQ: NETE) to Drive into US EV Market in Style, Speed via K50 Dragonfly

Net Element (NASDAQ: NETE) is a financial technology company in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc. The merger is optimally timed as … Continue reading

Posted in Net Element Inc. NETE | Leave a comment

Net Element, Inc. (NASDAQ: NETE) Prepares for Life in the Fast Lane as It Prepares to Shift into Electric Vehicle Space

Net Element plans to radically transform its business model following completion of merger with Mullen Technologies, converting into pure-play EV manufacturer Electric vehicles are set to account for 3% of global vehicle sales in 2020 Governments have increasingly pushed for … Continue reading

Posted in Net Element Inc. NETE | Leave a comment

MissionIRNewsBreaks – iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) Board Approves Share Repurchase Program Up to $15 Million

iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, and its board of directors has announced a share repurchase program. The program allows ICLK to purchase its own ADSs with an aggregate value of up … Continue reading

Posted in iClick Interactive Asia Group Ltd. ICLK, MissionIRNewsBreaks | Leave a comment

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Brain Cancer Drug IND Filing Accepted for Review by FDA

CNS Pharmaceuticals featured in audio broadcast distributed to thousands of syndication points. Berubicin IND accepted for review by FDA Phase 1 trial showed 44% of patients experiencing clinical benefit of stable disease or better Adult Phase 2 trials to commence … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Predictive Oncology (NASDAQ: POAI) Releases Third-Quarter 2020 Business Update, Financial Report

Financial numbers show revenues stay level, gross margins up and operations expenses down. Company continues focus on primary mission of applying artificial intelligence to precision medicine, drug discovery. POAI subsidiaries all showing progress, growth in key areas. Predictive Oncology (NASDAQ: … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Partners with KPH Healthcare Service to Provide Telehealth Services

Trxade Group (NASDAQ: MEDS), through its telehealth subsidiary Bonum Health, has signed a strategic agreement with KPH Healthcare Services (“KPH”), a leading pharmaceutical and healthcare services provider, to provide affordable telemedicine services to two KPH divisions. Trxade, an integrated drug procurement, … Continue reading

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Granted Patent for Innovative Treatment for MDD

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, has been granted a patent by the Korean Intellectual … Continue reading

Posted in VistaGen Therapeutics Inc. VTGN | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a research report by the Benchmark Company LLC. The report, titled “Processa … Continue reading

Posted in Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) on Track to Launch BaroShear K45 Nanoemulsification System in 2021

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently reported its third-quarter financial results and provided a business update, which included initial expectations for 2021 (https://ibn.fm/8PNFi). Among the updates, the … Continue reading

Posted in Pressure BioSciences Inc. PBIO | Leave a comment